Pantoprazole from Actavis launched on patent expiry in Germany, Ireland, Netherlands

Actavis Group, the international generic pharmaceuticals company, launched Pantoprazole tablets in Germany, Ireland, and the Netherlands as the patent expired on 6 May. This is Actavis Group's first own brand launch of this molecule. In Germany and the Netherlands, the product was also launched by Actavis' third party sales division's (Medis') ... Read More...

Actavis reintroduces Oxycodone in the US

Little Falls facility resumes production with FDA approval of critical pain solution Reykjavik, Iceland, 17 April 2009 -- Actavis Group, the international generic pharmaceuticals company, today announced the reintroduction by its subsidiary in the United States of Oxycodone 15 mg and 30 mg tablet products to pharmacies and customers. Oxycodone is ... Read More...

Fluvastatin SR from Actavis first to market in UK, Holland

Actavis Group, the international generic pharmaceuticals company, today announced the launch of Fluvastatin SR in the UK and the Netherlands. Actavis was first to market in both countries. Fluvastatin SR extended release tablets from Actavis are the generic equivalent of Novartis' Luvinsta® SR / Lescol® XL and are available in 80mg ... Read More...

Trust Realpharmacyrx.com to treat Erectile Dysfunction

Realpharmacyrx.com Pharmacy (http://www.realpharmacyrx.com) RealPharmacyrx-Online.com is a trusted and reliable online pharmacy for brand name and generic prescription drugs at a tremendous savings to thousands of customers worldwide. It is one of the most dedicated sites which provide its customers top quality medicines at the lowest prices online. They offer medication services ... Read More...

Study Shows that Flavonoid Supplements Prevent Impairment of Endothelial Function After High-Fat Meals

Itamar Medical, an international medical technology company developing noninvasive diagnostic technology using the Peripheral Arterial Tone (PAT™) Signal, announced today the use of the company's patented Endo-PAT2000 in the Carolinas HealthCare System's study of the potential benefits of flavonoid supplementation on endothelial function. The Endo-PAT2000 was used to measure participants' endothelial ... Read More...

R&D Labs in Florida division of Actavis open

New analytical and R&D laboratories to expand the research and development efforts for controlled release and other technically difficult generic pharmaceutical products opened in Actavis South Atlantic, a United States division of the international generic pharmaceutical company Actavis. The labs have been expanded by about 300 sq meters and the new ... Read More...

Actavis and Medis represented at CPhI

Actavis Group employees from diverse departments from all over the world will be present at this year's annual CPhI conference, held in Frankfurt, Germany, 30 September to 2 October. Actavis' third party sales division, Medis, had its own stand at the CPhI exhibition for 8 years, but shared the floor with ... Read More...

Actavis first to market generic prostate cancer drug Bicalutamide in the UK, Germany & France

Actavis, the international generic pharmaceuticals company, recently launched Bicalutamide tablets in the UK, Germany and France. Acuavis Bicalutamide is the first generic version of the oncology drug to be made available in the three markets. Actavis has launched a generic drug for prostate cancer, Bicalutamide, in the UK, France and Germany. Bicalutamide, ... Read More...